What does it take to move the needle on the acceptance of a surrogate endpoint in an HTA? In this clip from our recent webinar, Clare Foy (Director – Global Market Access, Mtech Access) summarises some of the challenges and calls for more guidance from HTA agencies globally.

Watch the full webinar and request a copy of the slides at: [ Ссылка ]

Learn more about our research into surrogate endpoints and their impact on HTA recommendations at: [ Ссылка ]

#surrogateendpoints #marketaccess #HTA #healtheconomics

свернуть